share_log

6-K: Report of foreign private issuer (related to financial reporting)

6-K: Report of foreign private issuer (related to financial reporting)

6-K：外國發行人報告（業績相關）
美股sec公告 ·  07/02 04:34
牛牛AI助理已提取核心訊息
TC BioPharm (Holdings) PLC, a foreign private issuer, filed a Form 6-K with the SEC for July 2024, indicating the indefinite adjournment of its first 2024 Annual General Meeting (AGM) due to insufficient quorum as per Nasdaq rules. The company, having satisfied UK quorum requirements, announced a second AGM scheduled for July 24, 2024, at its UK office. Shareholders of record as of July 22, 2024, are entitled to vote, with ADS holders voting by proxy before July 19, 2024. The agenda includes receiving the annual report, approving directors' remuneration, ratifying the appointment of Marcum LLP as the U.S. auditor, re-appointing Ecovis as the UK auditor, and authorizing the Audit Committee to determine auditor remuneration.
TC BioPharm (Holdings) PLC, a foreign private issuer, filed a Form 6-K with the SEC for July 2024, indicating the indefinite adjournment of its first 2024 Annual General Meeting (AGM) due to insufficient quorum as per Nasdaq rules. The company, having satisfied UK quorum requirements, announced a second AGM scheduled for July 24, 2024, at its UK office. Shareholders of record as of July 22, 2024, are entitled to vote, with ADS holders voting by proxy before July 19, 2024. The agenda includes receiving the annual report, approving directors' remuneration, ratifying the appointment of Marcum LLP as the U.S. auditor, re-appointing Ecovis as the UK auditor, and authorizing the Audit Committee to determine auditor remuneration.
TC BioPharm (Holdings) PLC，一家外國私人發行人，於2024年7月向SEC提交了6-K表格，表示根據納斯達克規則由於參會人數不足而無限期休會其2024年首次年度股東大會（AGM）。該公司已經滿足英國法定人數要求，宣佈將於2024年7月24日在英國辦公室舉行第二次股東大會。自2024年7月22日記錄日起，股東有權進行投票，ADS持有人需在2024年7月19日前按照代理方式進行投票。議程包括通過年度報告、批准董事酬金、批准Marcum LLP擔任美國核數師、再任命Ecovis爲英國核數師並授權審計委員會判斷會計師費用的事宜。
TC BioPharm (Holdings) PLC，一家外國私人發行人，於2024年7月向SEC提交了6-K表格，表示根據納斯達克規則由於參會人數不足而無限期休會其2024年首次年度股東大會（AGM）。該公司已經滿足英國法定人數要求，宣佈將於2024年7月24日在英國辦公室舉行第二次股東大會。自2024年7月22日記錄日起，股東有權進行投票，ADS持有人需在2024年7月19日前按照代理方式進行投票。議程包括通過年度報告、批准董事酬金、批准Marcum LLP擔任美國核數師、再任命Ecovis爲英國核數師並授權審計委員會判斷會計師費用的事宜。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。